CUE BIOPHARMA INC's ticker is CUE and the CUSIP is 22978P106. A total of 73 filers reported holding CUE BIOPHARMA INC in Q2 2024. The put-call ratio across all filers is 0.20 and the average weighting 0.0%.
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Slate Path Capital LP | 890,000 | $7,503,000 | 0.50% |
Nantahala Capital Management | 1,378,198 | $11,618,000 | 0.43% |
683 Capital Management, LLC | 300,000 | $2,529,000 | 0.28% |
Rock Creek Group, LP | 42,505 | $358,000 | 0.17% |
SPHERA FUNDS MANAGEMENT LTD. | 50,000 | $422,000 | 0.06% |
Parian Global Management LP | 11,000 | $93,000 | 0.04% |
Sigma Planning Corp | 60,210 | $508,000 | 0.02% |
D'Orazio & Associates, Inc. | 2,000 | $17,000 | 0.01% |
OXFORD ASSET MANAGEMENT LLP | 26,602 | $224,000 | 0.01% |
STIFEL FINANCIAL CORP | 55,855 | $471,000 | 0.00% |